In episode 4 of Ai Meets Life Sci, Kayleen Brown, managing editor at DeviceTalks and Brian Buntz, pharma and biotech editor, chat with Helen Merianos, Ph.D., head of R+D portfolio strategy at Sanofi and Michelle Longmire, MD, CEO of Medable. The focus? The two-fold application of AI in their respective companies’ technologies, both for scientific advancement and business productivity, were central themes. Sanofi is applying AI across the company, encouraging an inquisitive culture around product development. AI also aids in making more data-driven investments across various domains. Medable is tapping AI to build a culture of invention as decentralized clinical trials become more operationalized and scalable.
Tune in and subscribe to AI Meets Life Sci on all major podcast channels and follow youtube.com/@DeviceTalks or AI Meets Life Sci YouTube Podcast to ensure you never miss an episode.
Sanofi embraces AI for improved decision-makingIn a June 2023 press rele…